Is the FDA Complicit in the Healthcare Crisis?
The FDA’s restrictive policies on the importation of affordable generic medications from countries like India raise significant concerns about their impact on healthcare costs and access. Critics argue these regulations favor Big Pharma’s interests, leading to higher drug prices and compromised consumer health. Ashvin Medicara advocates for policy reevaluation to ensure essential medications are accessible without compromising safety.